PT Brigit Biofarmaka Technologi Tbk (IDX:OBAT)
505.00
-30.00 (-5.61%)
At close: May 2, 2025, 3:30 PM WIB
IDX:OBAT Balance Sheet
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 6,371 | 3,988 | 989.7 | 1,964 |
Short-Term Investments | 820 | - | - | - |
Cash & Short-Term Investments | 7,191 | 3,988 | 989.7 | 1,964 |
Cash Growth | 80.34% | 302.93% | -49.60% | - |
Accounts Receivable | 3,878 | 2,616 | 611.4 | 605.18 |
Other Receivables | 34.21 | - | - | - |
Receivables | 3,912 | 2,616 | 611.4 | 605.18 |
Inventory | 20,080 | 8,006 | 5,061 | 3,332 |
Prepaid Expenses | 1,321 | - | - | - |
Other Current Assets | 2,592 | 27 | 19.17 | 19.17 |
Total Current Assets | 35,096 | 14,637 | 6,681 | 5,921 |
Property, Plant & Equipment | 23,233 | 18,743 | 13,155 | 7,124 |
Long-Term Investments | 176.02 | 354.81 | 375.08 | - |
Long-Term Deferred Tax Assets | 11.52 | 6.73 | 2.14 | 1.54 |
Other Long-Term Assets | 7,369 | 2,557 | 5,453 | 11,729 |
Total Assets | 65,886 | 36,298 | 25,666 | 24,775 |
Accounts Payable | 376.95 | 881.16 | 743.39 | 314.6 |
Accrued Expenses | 831.64 | 1,078 | 124.64 | - |
Current Portion of Long-Term Debt | 527.08 | 27.36 | 250.53 | 27.36 |
Current Portion of Leases | 59.12 | 96.38 | 63.01 | 47.18 |
Current Income Taxes Payable | 7,844 | 10,308 | 7,411 | 4,186 |
Current Unearned Revenue | 1,794 | 2,452 | 1,383 | 1,488 |
Total Current Liabilities | 11,433 | 14,843 | 9,975 | 6,063 |
Long-Term Debt | 8,523 | 1,427 | 29.64 | 57 |
Long-Term Leases | 398.98 | 238.03 | 36.97 | 44.24 |
Other Long-Term Liabilities | 1,820 | 429.32 | 244.54 | 316.56 |
Total Liabilities | 22,196 | 16,955 | 10,292 | 6,483 |
Common Stock | 21,500 | 2,000 | 2,000 | 500 |
Additional Paid-In Capital | 505.71 | 1,361 | 1,522 | - |
Retained Earnings | 20,252 | 16,651 | 12,379 | 16,010 |
Comprehensive Income & Other | 1.01 | -1,397 | -1,058 | 1,671 |
Total Common Equity | 42,259 | 18,616 | 14,843 | 18,182 |
Minority Interest | 1,431 | 727.9 | 531.26 | 109.83 |
Shareholders' Equity | 43,690 | 19,344 | 15,374 | 18,292 |
Total Liabilities & Equity | 65,886 | 36,298 | 25,666 | 24,775 |
Total Debt | 9,509 | 1,789 | 380.15 | 175.78 |
Net Cash (Debt) | -2,317 | 2,199 | 609.54 | 1,788 |
Net Cash Growth | - | 260.71% | -65.91% | - |
Net Cash Per Share | -3.86 | 5.11 | 1.32 | 3.86 |
Filing Date Shares Outstanding | 600 | 40 | 463 | 463 |
Total Common Shares Outstanding | 600 | 40 | 463 | 463 |
Working Capital | 23,663 | -206.08 | -3,294 | -142.5 |
Book Value Per Share | 70.43 | 465.39 | 32.06 | 39.27 |
Tangible Book Value | 42,259 | 18,616 | 14,843 | 18,182 |
Tangible Book Value Per Share | 70.43 | 465.39 | 32.06 | 39.27 |
Land | 2,310 | 2,310 | - | - |
Buildings | 13,910 | 10,665 | 9,523 | 4,961 |
Machinery | 12,683 | 10,117 | 6,209 | 3,492 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.